Analysis of the promoter-specific estrogenic potency of the phytoestrogens genistein, daidzein and coumestrol

Planta Medica

Volumn 72, Issue 2, 2006, Pages 184-186

  Zierau, Oliver ^a   Kolba, Susanne ^a   Olff, Sabine ^b   Vollmer, Günter ^a   Diel, Patrick ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COUMESTROL; DAIDZEIN; GENISTEIN; INTERLEUKIN 6; PHYTOESTROGEN;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENCY; HORMONE BINDING; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PROMOTER REGION; REPORTER GENE;

CELL LINE, TUMOR; COUMESTROL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENES, REPORTER; GENISTEIN; HUMANS; ISOFLAVONES; PHYTOESTROGENS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC;

EID: 33644527272     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-873182     Document Type: Article

References (12)

1. Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obstet Gynecol 1996; 87: 897-904
2. Krishnan V, Heath H, Bryant HU. Mechanism of action of estrogens and selective estrogen receptor modulators. Vitam Horm 2000; 60: 123-47
3. O'Lone R, Frith MC, Karlsson EK, Hansen U. Genomic targets of nuclear estrogen receptors. Mol Endocrinol 2004; 18: 1859-75
4. McDonnell DP. The molecular determinants of estrogen receptor pharmacology. Maturitas 2004; 48 (Suppl 1): 7-12
5. McKay LI, Cidlowski JA. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr Rev 1999; 20: 435-59
6. Kurebayashi S, Miyashita Y, Hirose T, Kasayama S, Akira S, Kishimoto T. Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor. J Steroid Biochem Mol Biol 1997; 60: 11-7
7. Cos P, De Bruyne T, Apers S, Vanden Berghe D, Pieters L, Vlietinck AJ. Phytoestrogens: recent developments. Planta Med 2003; 69: 589-99
8. Krebs EE, Ensrud KE, MacDonald R, Wilt TJ. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 2004; 104: 824-36
9. Pons M, Gagne D, Nicolas JC, Mehtali M. A new cellular model of response to estrogens: a bioluminescent test to characterize (anti) estrogen molecules. Biotechniques 1990; 9: 450-9
10. Demirpence E, Duchesne MJ, Badia E, Gagne D, Pons M. MVLN cells: a bioluminescent MCE-7-derived cell line to study the modulation of estrogenic activity. Steroid Biochem Mol Biol 1993; 46: 355-64
11. Pottratz ST, Bellido T, Mocharla H, Crabb D, Manolagas SC. 17beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 1994; 93: 944-50
12. Tora L, White J, Brou C, Tasset D, Webster N, Scheer E et al. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 1989; 59: 477-87